Search Results 1021-1030 of 21769 for Secondary
Because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with this DNA vaccine, breastfeeding ...
Secondary objective is to investigate the safety, pharmacokinetics and efficacy of BI 836858 in combination with decitabine Phase I Extension: Primary ...
PGY-1 Pharmacy Residency at Mayo Clinic Health System — Mankato Medical Emergency Response and MUE-QI. Secondary Navigation. Overview · Application Process ...
This is a single arm prospective study with 30 patients eligible for implantation of an ICD for the secondary prevention of sudden cardiac death. Spontaneous ...
... secondary treatment interventions sought) for individuals who undergo ultrasound guided Achilles and patellar tendon scraping for tendinopathy. Outcomes ...
Secondary Genetic Findings: Do You Want to Know? Community. July 20, 2015. Health & Wellness. Repairing Fatal Mutations Behind Mitochondrial Disease. Robert ...
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...
Secondary Objectives: Part 1: - To assess the pharmacokinetic (PK) profile of oral dosing of GZ/SAR4027671 in plasma when administered in early-stage ...
... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...
... secondary outcomes such as improvement in pain, spasticity, quality of life, cardiovascular (blood pressure) and autonomic function. Spinal Cord Stimulation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.